HSAN1 mutations in serine palmitoyltransferase reveal a close structure–function–phenotype relationship

Heiko Bode(University of Zurich), Thorsten Hornemann(University Hospital of Zurich), Alaa Othman(University of Zurich), Irina Alecu(University of Zurich), Wei Yu(Ocean University of China), Saranya Suriyanarayanan(University Hospital Zurich), Florence Bourquin(University of Zurich), Arnold von Eckardstein(University Hospital of Zurich)
Human Molecular Genetics
December 17, 2015
10.1093/hmg/ddv611
Cited by 90

Related Papers

Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement
|European Heart Journal|2022|1.3k
Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine
|European Heart Journal|2016|830
High-Density Lipoproteins
|Circulation Journal|2013|179
DEGS1-associated aberrant sphingolipid metabolism impairs nervous system function in humans
|Journal of Clinical Investigation|2019|131
Randomized trial of <scp>l</scp> -serine in patients with hereditary sensory and autonomic neuropathy type 1
|Neurology|2019|116